138 related articles for article (PubMed ID: 12118689)
1. Hematological toxicity and therapeutic efficacy of lomustine in 20 tumor-bearing cats: critical assessment of a practical dosing regimen.
Fan TM; Kitchell BE; Dhaliwal RS; Jones PD; Hintermeister JG; Paria BC
J Am Anim Hosp Assoc; 2002; 38(4):357-63. PubMed ID: 12118689
[TBL] [Abstract][Full Text] [Related]
2. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
[TBL] [Abstract][Full Text] [Related]
3. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
Heading KL; Brockley LK; Bennett PF
Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
[TBL] [Abstract][Full Text] [Related]
5. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats.
Rassnick KM; Gieger TL; Williams LE; Ruslander DM; Northrup NC; Kristal O; Myers NC; Moore AS
J Vet Intern Med; 2001; 15(3):196-9. PubMed ID: 11380027
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of lomustine as a rescue agent for cats with resistant lymphoma.
Dutelle AL; Bulman-Fleming JC; Lewis CA; Rosenberg MP
J Feline Med Surg; 2012 Oct; 14(10):694-700. PubMed ID: 22577051
[TBL] [Abstract][Full Text] [Related]
7. Tolerability of metronomic administration of lomustine in dogs with cancer.
Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN
J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727
[TBL] [Abstract][Full Text] [Related]
8. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE
J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719
[TBL] [Abstract][Full Text] [Related]
9. A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
Rau SE; Burgess KE
Vet Comp Oncol; 2017 Sep; 15(3):1019-1028. PubMed ID: 27277825
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat.
Skorupski KA; Durham AC; Duda L; Sørenmo KU
Vet Comp Oncol; 2008 Jun; 6(2):120-5. PubMed ID: 19178671
[TBL] [Abstract][Full Text] [Related]
11. Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats.
Musser ML; Quinn HT; Chretin JD
J Feline Med Surg; 2012 Dec; 14(12):871-5. PubMed ID: 22772480
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study.
Kisseberth WC; Vail DM; Yaissle J; Jeglum KA; Couto CG; Ward H; Khanna C; Obradovich JE
J Vet Intern Med; 2008; 22(1):83-8. PubMed ID: 18289293
[TBL] [Abstract][Full Text] [Related]
13. Dosage escalation of intravenous cyclophosphamide in cats with cancer.
Moore AS; Frimberger AE; Chan CM
Vet J; 2018 Dec; 242():39-43. PubMed ID: 30503542
[TBL] [Abstract][Full Text] [Related]
14. Overdose of lomustine: report of two cases.
Büyükçelik A; Akbulut H; Yalçin B; Ozdemir F; Içli F
Tumori; 2004; 90(6):628-9. PubMed ID: 15762370
[TBL] [Abstract][Full Text] [Related]
15. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
[TBL] [Abstract][Full Text] [Related]
16. Use of lomustine to treat cutaneous nonepitheliotropic lymphoma in a cat.
Komori S; Nakamura S; Takahashi K; Tagawa M
J Am Vet Med Assoc; 2005 Jan; 226(2):237-9, 219. PubMed ID: 15706974
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcoma.
Saba CF; Vail DM; Thamm DH
Vet Comp Oncol; 2012 Dec; 10(4):283-91. PubMed ID: 22236148
[TBL] [Abstract][Full Text] [Related]
18. The use of lithium carbonate to prevent lomustine-induced myelosuppression in dogs: a pilot study.
Abrams-Ogg AC
Can J Vet Res; 2011 Jan; 75(1):73-6. PubMed ID: 21461200
[TBL] [Abstract][Full Text] [Related]
19. Treatment-related toxicities in tumor-bearing cats treated with temozolomide alone or in combination with doxorubicin: a pilot assessment.
Gagnon J; Dervisis NG; Kitchell BE
J Feline Med Surg; 2012 Aug; 14(8):560-5. PubMed ID: 22496148
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of nimustine use in the treatment of feline lymphoma.
Sakai K; Hatoya S; Furuya M; Nabetani T; Kanegi R; Shimamura S; Tani H; Shimada T
Vet Med Sci; 2022 Jan; 8(1):3-8. PubMed ID: 34599792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
